Analyst Price Targets — PHAR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 8, 2026 12:55 pm | — | Oppenheimer | $40.00 | $12.91 | TheFly | Pharming price target lowered to $40 from $41 at Oppenheimer |
| April 10, 2026 10:59 am | Whitney Ijem | Canaccord Genuity | $37.00 | $17.50 | TheFly | Pharming initiated with a Buy at Canaccord on growth potential |
| March 12, 2026 3:53 pm | Joseph Pantginis | H.C. Wainwright | $37.00 | $15.58 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Pharming Group (PHAR): "well positioned to drive value" |
| November 7, 2025 1:27 pm | — | Oppenheimer | $42.00 | $15.96 | TheFly | Pharming price target raised to $42 from $41 at Oppenheimer |
| December 9, 2024 9:36 am | Lucy Codrington | Jefferies | $14.00 | $7.72 | StreetInsider | Jefferies Starts Pharming Group (PHAR) at Buy |
Latest News for PHAR
Launch marks first commercial availability of Joenja (leniolisib) for children aged 4 to 11 worldwide OrphanPacific, Inc. serves as Marketing Authorization holder and is responsible for supply and distribution in Japan Leiden, the Netherlands, August 13, 2026: Pharming Group (Euronext Amsterdam: PHARM/Nasdaq: PHAR), today announced the commercial launch of Joenja (leniolisib) in Japan for adult and pediatric…
Pharming Group told investors to expect up to $425 million in 2026 revenue. The Company now expects as little as $375 million -- and the stock lost 22% in a single session.
Ratio Petroleum Energy has raised its recommended offer for Pharos Energy (LSE:PHAR) to 32.8183p per share, trumping a rival bid from Serica Energy PLC (AIM:SQZ) and valuing the company at around £146.4 million. The revised terms comprise 28.8183p in cash plus a 4p special dividend.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Pharming Group N.V. (“Pharming” or the “Company”) (NASDAQ: PHAR) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PHARMING GROUP N.V. (PHAR), CLICK HERE TO…
Law Offices of Howard G. Smith announces an investigation on behalf of Pharming Group N.V. (âPharmingâ or the âCompanyâ) (NASDAQ: [url="]PHAR[/url]) inv
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PHAR.
U.S. House Trading
No House trades found for PHAR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.